Kenley Jansen was hospitalized in Denver earlier this week due to an irregular heartbeat. He missed a month last season with the very same issue and he’ll soon find out whether his recent scare will cost him the rest of the season.
According to Dylan Hernandez of the Los Angeles Times, Jansen threw a 25-pitch bullpen session on Friday and plans to play catch today. He’s scheduled to see a heart specialist on Tuesday, who will tell him whether he must continue taking a a blood-thinning medication. His medication prevents clots and strokes, but can also cause severe bleeding. He could bleed to death if he was struck by a baseball, so he isn’t even allowed to sit in the dugout while taking the medication.
If Jansen is cleared by the specialist, he could pitch again as soon as next Friday against the Giants. However, if he is instructed to continue taking the medication, he will not be allowed to throw for four weeks. That would essentially end his season.
Health obviously comes first here, but it’s still a tough break for Jansen, who stepped into the closer role at the end of April and has a 2.54 ERA and 86/19 K/BB ratio over 56 1/3 innings this season. Brandon League and Ronald Belisario are expected to split save chances during his absence.
At the end of April, Marlins second baseman Dee Gordon was handed an 80-game suspension by Major League Baseball after testing positive for exogenous testosterone and Clostebol, performance-enhancing drugs. Gordon says he took those substances unknowingly.
Gordon will return to the Marlins on Thursday, MLB.com’s Joe Frisaro reports. The club was 10-11 prior to Gordon’s suspension. Since then, the club has gone 43-35 and is now tied with the Mets for second place in the NL East, five games behind the Nationals. Impressively, the Marlins have collectively hit .272/.330/.408 in Gordon’s absence, which compares favorably to the league average .252/.320/.410 triple-slash line.
Gordon, who made the NL All-Star team in 2014 and ’15, was hitting .266/.289/.340 with three doubles, two triples, five RBI, 13 runs scored, and six stolen bases in 97 plate appearances. Derek Dietrich has handled second base in the meantime and has done an admirable job, batting .275/.366/.398 with 22 extra-base hits, 30 RBI, and 26 runs scored in 314 PA. Nevertheless, Gordon is likely to return to full-time duty at second base.
Update (10:12 AM EDT): Jon Heyman of Today’s Knuckleball reports the Padres will receive pitcher Hansel Rodriguez from the Blue Jays. Rodriguez is rated as the Jays’ 18th-best prospect by MLB Pipeline. The Jays signed Rodriguez out of the Dominican Republic for $330,000 in February 2014. He’s spent the 2016 season with the Bluefield Blue Jays in rookie ball, compiling a 3.06 ERA with a 26/11 K/BB ratio in 32 1/3 innings over six starts.
The Padres and Blue Jays have agreed on a trade involving outfielder Melvin Upton, Ken Rosenthal of FOX Sports reported on Tuesday morning. The Jays will get Upton and the Padres will receive a prospect from Single-A. The financial details are not yet known, but Dennis Lin of the San Diego Union-Tribune says the Padres are expected to cover a significant portion of his remaining contract. The trade is likely to be finalized on Tuesday.
The two teams opened up a three-game series in Toronto on Monday, so Upton won’t have to go very far to join his new team. The Jays won 4-2 on Monday.
Upton, 31, has had another solid season for the Padres, batting .256/.304/.439 with 16 home runs, 45 RBI, 46 runs scored, and 20 stolen bases in 374 plate appearances. He’s owed the remainder of his $15.45 million salary for the 2016 season and $16.45 million next season, the final year of his five-year contract.
Upton will provide some outfield depth for the Jays, who currently only have Ezequiel Carrera as a full-time back-up outfielder behind Michael Saunders, Kevin Pillar, and Jose Bautista. Bautista was activated from the disabled list on Monday, so Upton could cover right field in the event that Bautista exacerbates his toe injury.
With Upton leaving San Diego, Alex Dickerson is likely to see full-time work in left field in the short term. Prospects Hunter Renfroe and Manuel Margot could be called up at some point this season as well.